🔎 Trials Near Me

홈 › 흑색종 › 버지니아

버지니아의 흑색종 임상 시험

흑색종 관련 연구 34개가 버지니아 내 여러 지역에서 참여자를 모집하고 있습니다.

버지니아의 도시

공식 연구 텍스트(영어)

A Study of BI 3810944 in Patients With Advanced Cancer

  • University of Virginia Health System, Charlottesville
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 29. 업데이트됨 · NCT07224425

A Clinical Study of Intismeran Autogene (V940) and Pembrolizumab (MK-3475) in People With Melanoma (V940-012/INTerpath-012)

  • Inova Schar Cancer Institute ( Site 4046), Fairfax
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT06961006

Phase 1 Study of PF-08046033 in Advanced Solid Tumors

  • Inova Schar Cancer Infusion Pharmacy, Fairfax
  • Inova Schar Cancer, Fairfax
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT07519655

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

  • University of Virginia, Charlottesville
  • Inova Schar Cancer Institute, Fairfax
  • Virginia Commonwealth University Massey Cancer Center, Richmond
  • 외 1개
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06246916

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

  • Inova Alexandria Hospital, Alexandria
  • Inova Schar Cancer Institute, Fairfax
  • Inova Fair Oaks Hospital, Fairfax
  • 외 6개
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT05136196

Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma

  • University of Virginia Cancer Center, Charlottesville
  • VCU Massey Cancer Center at Stony Point, Richmond
  • VCU Massey Comprehensive Cancer Center, Richmond
피험자 모집 중3상
75세 이상 · 모든 성별 · 2026. 9. 24. 업데이트됨 · NCT07068074

Pan-tumor MRD Study

  • Virginia Cancer Institute, Richmond
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 9. 24. 업데이트됨 · NCT06605404

Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors

  • Virginia Cancer Specialists-Fairfax, Fairfax
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 4. 업데이트됨 · NCT07287917

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Chesapeake Regional Medical Center, Chesapeake
  • Augusta Health Center for Cancer and Blood Disorders, Fishersville
  • Bon Secours Memorial Regional Medical Center, Mechanicsville
  • 외 7개
피험자 모집 중관찰 연구건강한 지원자 환영
40세 ~ 75세 · 모든 성별 · 2026. 9. 2. 업데이트됨 · NCT05334069

A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors

  • Virginia Cancer Specialists, Fairfax
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 2. 업데이트됨 · NCT04913285

Project: Every Child for Younger Patients With Cancer

  • University of Virginia Cancer Center, Charlottesville
  • Inova Fairfax Hospital, Falls Church
  • Children's Hospital of The King's Daughters, Norfolk
  • 외 3개
피험자 모집 중관찰 연구
25세 이하 · 모든 성별 · 2026. 8. 25. 업데이트됨 · NCT02402244

A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors

  • Research Site, Fairfax
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 8. 19. 업데이트됨 · NCT07115043

Safety and Tolerability Study of GIM-531 in Advanced Solid Tumors

  • Virginia Commonwealth University, Richmond
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 8. 14. 업데이트됨 · NCT06425926

A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors

  • Clinical Trial Site, Fairfax
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 8. 6. 업데이트됨 · NCT07749586

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

  • Virginia Cancer Specialists, Fairfax
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 8. 5. 업데이트됨 · NCT06330064

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

  • NEXT Virginia, Fairfax
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 8. 3. 업데이트됨 · NCT06270706

DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors

  • USA05-0, Virginia Beach
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 5. 22. 업데이트됨 · NCT06953089

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

  • Next Oncology Virginia, Fairfax
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 5. 15. 업데이트됨 · NCT05379985

Neoadjuvant Darovasertib in Primary Uveal Melanoma

  • Augusta Health, Center for Cancer and Blood Disorders, Fishersville
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 5. 6. 업데이트됨 · NCT07015190

A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors

  • NEXT Oncology - Virginia, Fairfax
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 4. 20. 업데이트됨 · NCT06326411

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

  • Augusta Health Center for Cancer and Blood Disorders, Fishersville
  • Hematology Oncology Associates of Fredericksburg Inc, Fredericksburg
  • Centra Alan B Pearson Regional Cancer Center, Lynchburg
  • 외 5개
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 3. 17. 업데이트됨 · NCT06418204

A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors

  • NEXT Virginia, Fairfax
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 1. 21. 업데이트됨 · NCT07317505

Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients

  • VCU - McGlothlin Medical Education Center, Richmond
피험자 모집 중3상
18세 이상 · 모든 성별 · 2025. 12. 17. 업데이트됨 · NCT03567889

Study to Evaluate LB-LR1109, Administered Alone for the Treatment of Solid Tumor and in Combination With Atezolizumab for the Treatment of NSCLC

  • NEXT Oncology, Fairfax
피험자 모집 중1상
18세 이상 · 모든 성별 · 2025. 11. 24. 업데이트됨 · NCT06332755

A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

  • Research Site 102, Fairfax
  • Research Site 112, Fairfax
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2025. 11. 21. 업데이트됨 · NCT05914116

FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma

  • University of Virginia, Charlottesville
피험자 모집 중초기 1상
18세 이상 · 모든 성별 · 2025. 11. 20. 업데이트됨 · NCT06472661

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Charlottesville
피험자 모집 중관찰 연구
전 연령 · 모든 성별 · 2025. 10. 28. 업데이트됨 · NCT03452774

A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors

  • Virginia Cancer Specialists, Fairfax
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2025. 10. 8. 업데이트됨 · NCT04370587

Excision of Lymph Node Trial (EXCILYNT) (Mel69)

  • Cancer Center at the University of Virginia, Charlottesville
피험자 모집 중
18세 이상 · 모든 성별 · 2025. 9. 17. 업데이트됨 · NCT05839912

A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies

  • Virginia Cancer Specialists, Fairfax
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2025. 2. 13. 업데이트됨 · NCT05669430

A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents

  • NEXT Virginia, Fairfax
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2025. 1. 7. 업데이트됨 · NCT06090266

Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

  • University of Virginia Health System, Charlottesville
  • VCU Massey Cancer Center Peninsula Cancer Institute, Newport News
  • VCU Massey Cancer Center, Richmond
  • 외 2개
피험자 모집 중
18세 이상 · 모든 성별 · 2024. 11. 27. 업데이트됨 · NCT03860883

Phase II Trial of Neoadjuvant and Adjuvant IO102-IO103 and Pembrolizumab KEYTRUDA® in Patients With Resectable Tumors

  • Massey Cancer Center, Richmond
피험자 모집 중2상
18세 이상 · 모든 성별 · 2024. 3. 18. 업데이트됨 · NCT05280314

A First-in-human, Phase I, Open-label, Multicenter Study of NM1F(Anti-PVRIG) in Patients With Advanced Solid Tumors

  • Next Oncology, Virginia Cancer Specialists, Fairfax
피험자 모집 중1상
18세 이상 · 모든 성별 · 2024. 1. 26. 업데이트됨 · NCT05746897

ClinicalTrials.gov 출처, 2026. 9. 30. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.